2.08
Health Catalyst Inc stock is traded at $2.08, with a volume of 423.78K.
It is up +3.48% in the last 24 hours and up +20.93% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$2.01
Open:
$2.01
24h Volume:
423.78K
Relative Volume:
0.29
Market Cap:
$153.70M
Revenue:
$302.48M
Net Income/Loss:
$-265.26M
P/E Ratio:
-0.5597
EPS:
-3.716
Net Cash Flow:
$-2.76M
1W Performance:
-7.56%
1M Performance:
+20.93%
6M Performance:
-7.56%
1Y Performance:
-45.97%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
2.08 | 153.70M | 302.48M | -265.26M | -2.76M | -3.716 |
|
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
HCAT|Health Catalyst Inc|Price:2.025|Chg%:+0.015 - TradingKey
Health Catalyst Inc (HCAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Impax Asset Management Group (HCAT) discloses 4M-share position in Health Catalyst - Stock Titan
HCAT Maintained by Canaccord Genuity -- Price Target Raised to $3.00 - GuruFocus
Health Catalyst (HCAT) awards 80,691 restricted stock units to company director - Stock Titan
Health Catalyst Declares Voting Results - marketscreener.com
Health Catalyst shareholders rejected charter restatement to phase out classified board structure - Bitget
Health Catalyst (NASDAQ: HCAT) holders back pay, auditor and retain classified board - Stock Titan
Health Catalyst, Commerce, and Paycom Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails - MarketBeat
Health Catalyst (HCAT) AGM 2026 Summary - Quartr
Health Catalyst Inc Annual Shareholders Meeting Transcript - GuruFocus
Health Catalyst investors approve directors, pay; board declassification fails - MSN
3 Reasons to Sell HCAT and 1 Stock to Buy Instead - Yahoo Finance
Health Catalyst (HCAT) Edges Higher at $2.29 – Can Resistance at $2.40 Be Broken?MACD Signal Stocks - dars.gov.et
HCAT Q1 2026 Earnings: EPS Beats Estimates by 14.3%, Shares Edge HigherDividend Increase Stocks - dars.gov.et
monday.com, Intuit, and Health Catalyst Stocks Trade Down, What You Need To Know - Yahoo Finance
Health Catalyst(HCAT) Stock Options Chain | Quotes & News - Moomoo
Price to earnings forward of Health Catalyst, Inc – NASDAQ:HCAT - TradingView
Price to sales forward of Health Catalyst, Inc – NASDAQ:HCAT - TradingView
Price to sales forward of Health Catalyst, Inc. – LS:A2PH3J - TradingView
Health Catalyst Company Profile & Introduction - Moomoo
Discover Health Catalyst And 2 More Promising Penny Stocks - simplywall.st
Enterprise value to EBITDA forward of Health Catalyst, Inc – NASDAQ:HCAT - TradingView
A Quick Look at Today's Ratings for Health Catalyst(HCAT.US), With a Forecast Between $1.75 to $2 - Moomoo
Health Catalyst, PubMatic, and PTC Stocks Trade Up, What You Need To Know - Yahoo Finance
HCATHealth Catalyst Inc Options - Finviz
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Index - marketscreener.com
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Value Benchmark - marketscreener.com
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 3000E Index - marketscreener.com
Health Catalyst, Inc.(NasdaqGS:HCAT) dropped from Russell Small Cap Completeness Index - marketscreener.com
Health Catalyst (HCAT) Surges 7.3% as Positive Momentum Builds Above Key SupportOn Balance Volume - dars.gov.et
Health Catalyst Inc (HCAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HCAT Maintained by Wells Fargo -- Price Target Raised to $1.75 - GuruFocus
Health Catalyst Inc (HCAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
What's Driving the Recent Buzz Around Health Catalyst (HCAT) and ZoomInfo (ZI) Stocks - Kavout | AI
Data Analytics Stocks Q1 Highlights: Health Catalyst (NASDAQ:HCAT) - Yahoo Finance
Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know - Yahoo Finance
Ryan L. Vardeman discloses investment at Health Catalyst with 6.7% stake - TradingView
Palogic reports 6.7% Health Catalyst (HCAT) stake and outlines possible actions - Stock Titan
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains? - Yahoo Finance
Health Catalyst Inc (HCAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Health Catalyst Inc (HCAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Health Catalyst Inc (HCAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Health Catalyst Inc (HCAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Health Catalyst Inc (HCAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Health Catalyst Inc (HCAT) Institutional Confidence - TradingKey
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst and Paycom shares are falling, what you need to know - MSN
Health Catalyst and Paycom Shares Are Falling, What You Need To Know - Yahoo Finance
AI ROI: real vs hype in healthcare, Health Catalyst CEO on June 24 panel - Stock Titan
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):